Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for improving phloroglucinol synthetic capability of engineering escherichia coli

A technology of phloroglucinol and Escherichia coli, which is applied in the field of preparing phloroglucinol, can solve the problems of low yield, inappropriate synthesis of phloroglucinol and the like, and achieves the effect of improving synthesis capacity

Active Publication Date: 2012-11-21
QINGDAO INST OF BIOENERGY & BIOPROCESS TECH CHINESE ACADEMY OF SCI
View PDF2 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

On the other hand, phloroglucinol is not a normal metabolite of E. coli, and the metabolic flux of wild-type E. coli is not suitable for the efficient synthesis of phloroglucinol
Therefore, the output of the above-mentioned phloroglucinol synthetic engineering bacteria is still relatively low, and there is still a certain gap from the requirements of practical application.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for improving phloroglucinol synthetic capability of engineering escherichia coli
  • Method for improving phloroglucinol synthetic capability of engineering escherichia coli
  • Method for improving phloroglucinol synthetic capability of engineering escherichia coli

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Construction of polyketene anhydride synthase (phlD) and multiple resistance factor (marA) co-expressed carrier, the specific process is as follows:

[0041] Using oligonucleotides 5'-CAT GCC ATG GTA GAT AAA CGC GAA TC-3' and 5'-ACG CGT CGA CTC AGAAGG CAG ACG TAT CC-3' as primers, Pseudomonas fluorescens Pf-5[Psendomonas fluorescens Pf-5 (purchased from the American Type Culture Collection, ATCC BAA-477)] genomic DNA was used as a template, and the polyketene anhydride synthase (phlD) gene was amplified by the polymerase chain reaction (PCR) method, and NdeI and BamHI sites were introduced at the 5' end and 3' end, respectively, and then the gene was cloned into the pET30a (Novagen) vector that was also digested with NdeI and BamHI using the above restriction sites to obtain the recombinant plasmid pET-phlD; Using oligonucleotides 5'-CAT GCC ATG GGC ATG TCC AGA CGC AAT ACT GAC GC-3' and 5'-GGA GGA TCC TAG CTG TTG TAA TGA TTT AAT GGA TG-3' as primers, Escherichia coli BL...

Embodiment 2

[0045] The recombinant plasmids pET-phlDmarA and pA-accADBC constructed in Example 1 were co-transformed into Escherichia coli BL21 (DE3) by the heat shock transformation method, and then spread on cells with two resistances to kanamycin and chloramphenicol. Positive clones were screened on LB solid medium plate to obtain recombinant Escherichia coli BL21 / phlDACCasemarA.

Embodiment 3

[0047] The recombinant Escherichia coli BL21 / phlDACCasemarA constructed in Example 2 is used to ferment and produce phloroglucinol, and the steps are as follows:

[0048] Inoculate the recombinant cells at an inoculum volume of 1% by volume to add 50 μg·mL -1 Kanamycin and 30 μg·mL -1 Ferment in the M9 fermentation medium of chloramphenicol, cultivate to OD under the conditions of culture temperature 30°C, stirring speed 400rpm, pH 6.0 and dissolved oxygen 18% or more 600 About 8, add the inducer IPTG to the final concentration of 0.1mmol L -1 , continue feeding 40% by weight of glucose to ferment for 12 hours;

[0049] The culture medium was centrifuged to separate the cells and the supernatant, and the supernatant was extracted once with an equal volume of ethyl acetate;

[0050] The combined extraction products were concentrated by distillation under reduced pressure, and the resulting solid powder was subjected to proton nuclear magnetic resonance spectrum (see attached...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for improving phloroglucinol synthetic capability of recombinant cells, and particularly relates to a method for improving the yield of phloroglucinol synthesized by a biological method through recombinant cell reconstruction by metabolic engineering means.

Description

technical field [0001] The invention relates to an engineering Escherichia coli with high phloroglucinol production. The present invention also relates to a method for preparing phloroglucinol by using the above engineering Escherichia coli. Background technique [0002] Phloroglucinol, also known as 1,3,5-trihydroxybenzene and pyroglucinol, is an important fine chemical product and can be used as an intermediate in drug synthesis, fuel coupling agent, tire tackifier and azo composite ink It is widely used in the dyeing process of textiles and leather, the production of plastic capsules, and the replacement of silver iodide for artificial rainfall. In addition, phloroglucinol itself is an excellent pharmaceutical product, an anti-curing agent with superior performance, and has been widely used in antibacterial and antiseptic. [0003] As early as the 1950s, the chemical synthesis process of phloroglucinol had been established and applied to industrial production, including...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/70C12N15/78C12N1/21C12P7/22C12R1/19C12R1/39
Inventor 咸漠曹玉锦赵国明张海波
Owner QINGDAO INST OF BIOENERGY & BIOPROCESS TECH CHINESE ACADEMY OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com